StockWatch
·

Research Reports

02 Aug 2026
AUROPHARMAAUROBINDO PHARMA LTD.

Margin pivot and US consolidation: Aurobindo targets 21% EBITDA in FY27

margin recovery · US expansion · Lannett integration

Result previewQ1 FY273 minPharma & Healthcare
01 Aug 2026
DIVISLABDIVI'S LABORATORIES LTD.

Divi's Q1: consolidated PAT surges 65% to ₹902 Cr on sharp margin expansion

pharma api · cdmo · custom synthesis

ResultsQ1 FY273 minPharma & Healthcare
31 Jul 2026
NHNarayana Hrudayalaya Ltd

Narayana Q1: consol revenue +78% on UK buyout, but margins squeeze PAT growth to just 5% YoY

hospitals · healthcare · margin compression

ResultsQ1 FY273 minPharma & Healthcare
GLENMARKGLENMARK PHARMACEUTICALS LTD.

Glenmark Q1: revenue +23% YoY, consolidated PAT ₹483 Cr on a clean, exceptional-free quarter

pharmaceuticals · us generics · revenue growth

ResultsQ1 FY273 minPharma & Healthcare
CONCORDBIOConcord Biotech Ltd

Concord Biotech's Q1 marks return to growth: consol PAT +31% YoY to ₹58 Cr, margins expand

pharmaceuticals · api · revenue rebound

ResultsQ1 FY273 minPharma & Healthcare
SUNPHARMASUN PHARMACEUTICAL INDUSTRIES LTD.

Sun Pharma Q1: sales +10.5%, but EBITDA margin slips to 28.9% and adjusted PAT up only ~3%

specialty pharma · margin compression · us generics decline

ResultsQ1 FY273 minPharma & Healthcare
STARStrides Pharma Science Ltd

Strides Q1 PAT ₹165 Cr up 57% YoY, but one-off Pivot Path gain masks flat core profit

pharma · us generics · exceptional gain

ResultsQ1 FY273 minPharma & Healthcare
30 Jul 2026
INDGNIndegene Ltd

Indegene Q1: revenue up 40% YoY but consolidated PAT flat at ₹116 Cr on margin squeeze

life sciences commercialization · pharma outsourcing · healthcare

ResultsQ1 FY273 minPharma & Healthcare
ALIVUSGlenmark Life Sciences Ltd

Alivus Q1 net profit up 32% YoY to ₹160 Cr as margins hit record ~33%

api · pharma · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
TORNTPHARMTORRENT PHARMACEUTICALS LTD.

Torrent Pharma revenue +55% on JB merger; consolidated PAT flat at ₹566 Cr as net margin compresses

pharma · jb pharma merger · acquisition-led growth

ResultsQ1 FY273 minPharma & Healthcare
RAINBOWRainbow Children's Medicare Ltd

Rainbow Q1: consolidated revenue +33% YoY to ₹470 Cr; PAT +16% as margins compress on expansion

hospitals · healthcare · revenue growth

ResultsQ1 FY273 minPharma & Healthcare
MEDANTAGlobal Health Ltd

Medanta Q1: revenue +26% YoY, consolidated PAT flat at Rs157 Cr as Noida ramp squeezes margins

hospitals · healthcare services · revenue growth

ResultsQ1 FY273 minPharma & Healthcare
MANKINDMankind Pharma Ltd

Mankind Pharma Q1: consolidated PAT up 29% YoY to ₹574 Cr on EBITDA margin expansion

pharma · domestic formulations · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
AJANTPHARMAJANTA PHARMA LTD.

Ajanta Pharma Q1: consolidated PAT up 31% to ₹334 Cr on 25% revenue jump, US +57%

pharma · branded generics · us generics

ResultsQ1 FY273 minPharma & Healthcare
AHCLAnlon Healthcare Ltd

Anlon Healthcare Q1 FY27: consolidated PAT ₹8.28 Cr, +134% YoY, margins dilute

api manufacturing · subsidiary consolidation · margin dilution

ResultsQ1 FY273 minPharma & Healthcare
HESTERBIOHESTER BIOSCIENCES LTD.

Hester Q1: Consol PAT +459% on one-off gain, but adjusted profit falls ~34% YoY

animal health vaccines · poultry growth · one-off gain

ResultsQ1 FY273 minPharma & Healthcare
29 Jul 2026
PPLPHARMAPiramal Pharma Ltd

Piramal Pharma: consolidated loss narrows YoY to Rs69cr as revenue beats street, up 17%

cdmo growth · consolidated net loss · revenue beats street

ResultsQ1 FY273 minPharma & Healthcare
SYNGENESyngene International Ltd

Syngene slips to a Q1 net loss as revenue falls 16% YoY; transition year begins weak

cro cdmo · contract research · librela destocking

ResultsQ1 FY273 minPharma & Healthcare
JAGSNPHARMJAGSONPAL PHARMACEUTICALS LTD.

Jagsonpal Q1 FY27: PAT +22% YoY on margin gains; revenue growth of 8.8% trails guidance

pharmaceuticals · margin expansion · share buyback

ResultsQ1 FY273 minPharma & Healthcare
28 Jul 2026
ZENOTECHZENOTECH LABORATORIES LTD.

Zenotech posts ₹0.46 Cr Q1 FY27 loss, reversing YoY profit; loss narrows 86% QoQ

pharmaceuticals · swing to loss · margin compression

ResultsQ1 FY273 minPharma & Healthcare
SYNGENESyngene International Ltd

Leadership Transition & Continuity: What Q1 Revenue Can Tell Us

CRO · contract-research · pharma-services

Result previewQ1 FY273 minPharma & Healthcare
27 Jul 2026
SENORESSenores Pharmaceuticals Ltd

Senores Q1: consolidated PAT ₹30.5 Cr, EBITDA +87% YoY as margins expand ~800bps

pharmaceuticals · andas · regulated markets

ResultsQ1 FY273 minPharma & Healthcare
TORNTPHARMTORRENT PHARMACEUTICALS LTD.

Integration milestone and margin momentum on tap as Torrent reports Q1

merger integration · organic growth · EBITDA margins

Result previewQ1 FY273 minPharma & Healthcare
MANKINDMankind Pharma Ltd

Expect momentum on scale; watch how divestment reshapes the play

Q1FY27 · revenue-growth · margin-track

Result previewQ1 FY273 minPharma & Healthcare
26 Jul 2026
DIVISLABDIVI'S LABORATORIES LTD.

Q1 Steady: Watch for Margin Hold Amid CDMO Ramp

CDMO · peptides · custom synthesis

Result previewQ1 FY273 minPharma & Healthcare
25 Jul 2026
DRREDDYDR.REDDY'S LABORATORIES LTD.

Dr Reddy's Q1 PAT sinks 69% YoY to ₹436 Cr as lenalidomide fades, semaglutide hit

pharma · us generics slowdown · lenalidomide roll-off

ResultsQ1 FY273 minPharma & Healthcare
SUNPHARMASUN PHARMACEUTICAL INDUSTRIES LTD.

Specialty Traction and Organon Integration Timing Set Q1 Tone

specialty drugs · Organon acquisition · margin expansion

Result previewQ1 FY273 minPharma & Healthcare
24 Jul 2026
LAURUSLABSLaurus Labs Ltd

Laurus Labs Q1: consolidated PAT more than doubles to ₹362 Cr as CDMO lifts margins

pharma · cdmo · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
23 Jul 2026
SOLARASolara Active Pharma Sciences Ltd

Solara Q1 PAT up 55% YoY to ₹16.3 Cr on 20% revenue growth; net margin widens to 4.3%

pharmaceuticals · active pharmaceutical ingredient · crams

ResultsQ1 FY273 minPharma & Healthcare
20 Jul 2026
BAJAJHCAREBajaj Healthcare Ltd

Bajaj Healthcare Q1 PAT +16% YoY to ₹13.7 Cr; margins expand after one-off Q4 loss

Pharma & Biotech · earnings · quarterly results

ResultsQ1 FY273 minPharma & Healthcare